Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
SU11274
Description:
SU11274 is a small-molecule inhibitor of the c-Met receptor tyrosine kinase studied in cancer biology and therapeutic research.
Related topic:
Lung Cancer Treatments and Mutations (16%)
OpenAlex ID:
keywords/su11274
Functional Expression and Mutations of c-Met and Its Therapeutic Inhibition with SU11274 and Small Interfering RNA in Non–Small Cell Lung Cancer
2005
·
Patrick C. Ma
, Ramasamy Jagadeeswaran
, et al.
·
Cancer Research
·
622
The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma
2009
·
Tanguy Y. Seiwert
, Ramasamy Jagadeeswaran
, et al.
·
Cancer Research
·
290
PDF
A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.
2003
·
Martin Sattler
, Yuri B Pride
, et al.
·
PubMed
·
256
Functional Analysis of c-Met/Hepatocyte Growth Factor Pathway in Malignant Pleural Mesothelioma
2006
·
Ramasamy Jagadeeswaran
, Patrick C. Ma
, et al.
·
Cancer Research
·
223
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer
2008
·
Neelu Puri
, Ravi Salgia
·
Journal of Carcinogenesis
·
219
Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer
2008
·
Z Tang
, R Du
, et al.
·
British Journal of Cancer
·
202
PDF
The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants
2004
·
Sylvie Berthou
, Daniel M Aebersold
, et al.
·
Oncogene
·
193
Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer
2016
·
Demin Jiao
, Jian Wang
, et al.
·
Molecular Therapy — Oncolytics
·
190
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma
2012
·
G.T. Gibney
, S.A. Aziz
, et al.
·
Annals of Oncology
·
187
Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion
2007
·
P C Ma
, M S Tretiakova
, et al.
·
British Journal of Cancer
·
181
PDF
c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma
2007
·
Neelu Puri
, Salman Ahmed
, et al.
·
Clinical Cancer Research
·
166
c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations
2007
·
Steven F. Bellon
, Paula Kaplan-Lefko
, et al.
·
Journal of Biological Chemistry
·
145
Elevated hepatocyte growth factor expression as an autocrine c‐Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells
2016
·
Zeynep Firtina Karagonlar
, Dogukan Koc
, et al.
·
Cancer Science
·
135
PDF
The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non–small Cell Lung Cancer Cells
2009
·
Shawn A. Milligan
, Patrick Burke
, et al.
·
Clinical Cancer Research
·
128
Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET
2013
·
Yiwu Dang
, Dianzhong Luo
, et al.
·
PLoS ONE
·
121
PDF
Identification of the Receptor Tyrosine Kinase c-Met and Its Ligand, Hepatocyte Growth Factor, as Therapeutic Targets in Clear Cell Sarcoma
2010
·
Ian J. Davis
, Andrew W. McFadden
, et al.
·
Cancer Research
·
121
HGF-independent potentiation of EGFR action by c-Met
2011
·
A M Dulak
, C T Gubish
, et al.
·
Oncogene
·
120
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription
2009
·
Rajani Kanteti
, Vidya Nallasura
, et al.
·
Laboratory Investigation
·
112
PDF
Co‐expression of hepatocyte growth factor and c‐Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c‐Met signaling in gastric cancer
2011
·
Yuji Toiyama
, Hiromi Yasuda
, et al.
·
International Journal of Cancer
·
109
RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma
2011
·
Daniel V.T. Catenacci
, Gustavo Cervantes
, et al.
·
Cancer Biology & Therapy
·
102
Role of c-Met/Phosphatidylinositol 3-Kinase (PI3k)/Akt Signaling in Hepatocyte Growth Factor (HGF)-mediated Lamellipodia Formation, Reactive Oxygen Species (ROS) Generation, and Motility of Lung Endothelial Cells
2014
·
Peter V. Usatyuk
, Panfeng Fu
, et al.
·
Journal of Biological Chemistry
·
100
The HGF Receptor/Met Tyrosine Kinase Is a Key Regulator of Dendritic Cell Migration in Skin Immunity
2012
·
Jea-Hyun Baek
, Carmen Birchmeier
, et al.
·
The Journal of Immunology
·
86
MET molecular mechanisms and therapies in lung cancer
2010
·
Ryan E. Lawrence
, Ravi Salgia
·
Cell Adhesion & Migration
·
85
PDF
Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer
2011
·
Geert J. L. H. van Leenders
, Rajesh Sookhlall
, et al.
·
PLoS ONE
·
80
PDF
(−)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells
2010
·
Christine A. Larsen
, Roderick H. Dashwood
·
Archives of Biochemistry and Biophysics
·
73
Show more works
View as search
Works count:
248
Citation count:
7,009
Year
Topic
Type